Key result
Antibodies to Ro(SS-A) were found in 34 of 41 mothers of infants with congenital complete heart block, suggesting it may serve as a marker to identify women at risk.
Why the study?
Does the presence of maternal Ro(SS-A) antibodies serve as a marker for risk of congenital complete heart block in infants?
Population
41 mothers who had given birth to infants with congenital complete heart block, and 21 affected infants.
Design
Editorial
Authors
Loading...
Maternal antibodies to Ro(SS-A) may serve as a marker to identify women at risk of having an infant with congenital complete heart block.
Does the presence of maternal Ro(SS-A) antibodies serve as a marker for risk of congenital complete heart block in infants?
Maternal antibodies to Ro(SS-A) may serve as a marker to identify women at risk of having an infant with congenital complete heart block.
Litsey et al. (1985) conducted a letter in Congenital complete heart block (n=41). Antibodies to Ro(SS-A) was evaluated on Presence of antibodies to Ro(SS-A). Antibodies to Ro(SS-A) were found in 34 of 41 mothers of infants with congenital complete heart block, suggesting it may serve as a marker to identify women at risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: